Series date: 
09/01/2019 - 7:00am CDT to 08/31/2020 - 4:00pm CDT
Location

Please check the individual session for location or broadcast availability.  


Frequency

Monthly


Series Director

Anneliese Gonzalez, MD


Target Audience and Needs

Physicians, residents, fellows, and community physicians need to be regularly updated on advances in the diagnosis and treatment of thyroid and endocrine cancer, as well as the clinical activities in the Division of Oncology.


Educational Methods

Educational methods will include case presentations and panel discussion.


Objectives

At the conclusion of the sessions, the participants should be able to:

  • Apply advances in research, diagnostics, therapy, and cancer epidemiology to improvements in thyroid and endocrine cancer treatment.
  • Describe the role of patient-based research in the management of thyroid and endocrinecancer.
  • Discuss how these advances can affect the treatment and management of thyroid and endocrinecancer.

Evaluation

Participants may be asked to complete a session evaluation.


Accreditation/Credit Designation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Baylor College of Medicine and The University of Texas Health Science Center at Houston. Baylor College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Series Coordinator 

Virginia Mohlere
[email protected]
832-325-7289

Series location: 
McGovern Medical School
6431 Fannin Street
Houston, TX 77030
United States

Sessions

There are no sessions in this series.